Stock NPCE NEUROPACE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features NeuroPace, Inc.

Equities

NPCE

US6412881053

Delayed Nasdaq
Other stock markets
 11:45:15 14/05/2024 pm IST 		5-day change 1st Jan Change
8.535 USD +0.18% Intraday chart for NeuroPace, Inc. -35.83% -17.22%
13/05 Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating MT
08/05 NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Temporary respite for the NasdaqTemporary respite for the Nasdaq January 19, 2022 at 08:35 pm IST
Analyst recommendations: Activision Blizzard, Chevron, Exxon Mobil, Gilead, Goldman Sachs...ANALYST RECOMMENDATIONS : Activision Blizzard, Chevron, Exxon Mobil, Gilead, Goldman Sachs... January 19, 2022 at 04:39 pm IST
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NPCE Stock
  4. News NeuroPace, Inc.
  5. MarketScreener Editorial Features
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW